Showing results (121-130 of 129) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Hemoglobin|May 24, 2011
Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patientsGaetano Restivo Pantalone, Aurelio Maggio, Angela Vitrano, et al.Blood|June 17, 2010
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panelVito Di Marco, Marcello Capra, Emanuele Angelucci, et al.British Journal of Haematology|October 26, 2021
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemiaKhaled M Musallam, Angela Vitrano, Antonella Meloni, et al.The Lancet. Haematology|May 30, 2020
Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trialAurelio Maggio, Antonis Kattamis, Mariagrazia Felisi, et al.Blood Cells, Molecules & Diseases|December 4, 2022
Development of a Thalassemia International Prognostic Scoring System (TIPSS)Angela Vitrano, Khaled M Musallam, Antonella Meloni, et al.Blood Cells, Molecules & Diseases|February 24, 2009
Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and HemoglobinopathiesAurelio Maggio, Angela Vitrano, Marcello Capra, et al.British Journal of Haematology|July 4, 2014
Hepatocellular carcinoma in thalassaemia: an update of the Italian RegistryCaterina Borgna-Pignatti, Maria Chiara Garani, Gian Luca Forni, et al.Nature Medicine|January 4, 2022
Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trialFarid Boulad, Aurelio Maggio, Xiuyan Wang, et al.European Journal of Haematology|January 29, 2016
Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNETAngela Vitrano, Giuseppina Calvaruso, Lorenzo Tesé, et al.Pageof 13